FDA Investigator Andrew Le
Andrew Le has conducted inspections on 12 sites in 2 countries as of 02 Apr 2024. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
12
Last Inspection Date:
02 Apr 2024
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America,
India
FDA Investigators that have inspected at least one site in common with Andrew Le:
Alan P Kurtzberg,
Alicia K Mckinsey,
Anastasia M Shields,
Angela E Glenn,
Anh M Lac,
Anita Narula, PhD,
Anney Lin,
Arsen Karapetyan,
Ashar P Parikh,
Barbara Janine Breithaupt,
Barbara M Frazier,
Binh T Nguyen,
Bryan L Mcguckin,
Caryn M Mcnab,
Cheryl A Clausen,
Christopher D Leach,
Claudia Mperez Kasmarski,
Courtney N Long,
Dandan Wang, PhD,
Darren S Brown,
Deborah A Greco,
Debra I Love,
Diane Cvan Leeuwen,
Esther B Gamallo Herrera,
Feiyan Jin,
Helen Verdel,
Henry K Lau,
Hung H Do, MS,
Jeffrey M Watson,
Jeffrey P Raimondi,
Jennifer C Adams,
Joey V Quitania,
John A Gonzalez,
Jolanna A Norton,
Jose R Hernandez,
Junho Pak,
Kham Phommachanh,
Khoa Nathanv Tran,
Kim Lthomas Cruse,
LCDR Jennifer H Rhyu,
Linda M Cheny,
Lisa Shin,
Makini Cobourne Duval, PhD,
Marijo B Kambere, PhD,
Matthew B Casale,
Melkamu Getie Kebtie, PhD,
Nayan J Patel,
Nicholas A Violand,
Paraluman S Leonin,
Parul M Patel,
Phillip L Toy,
Pratik S Upadhyay, DDC,
Rafeeq A Habeeb,
Robert J Doyle,
S Lori Brown, PhD MPH,
Sangeeta M Khurana, PhD,
Santiago Gallardo Johnson,
Sharon K Thoma, PharmD,
Stacey S Degarmo,
Taichun Qin, PhD,
Tamil Arasu, PhD,
Tenzin Jangchup,
Thomas J Arista,
Tracey T Duong,
Tracy K Li,
Truong Xuan Nguyen (Andy),
Virgilio F Pacio, CSO,
Zachary A Bogorad,
Zachary L Miller,
Zachary L Stamm
Andrew Le's Documents
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more